Research reactors rss

Bruce Power and ITM to supply cancer therapy isotope

Regulation and Safety

29 June 2018

Bruce-ITM_Lu-177_MOU_June18_(Bruce)-48Bruce Power and ITG, a subsidiary of radiopharmaceutical technology company ITM Isotopen Technologien München, have launched a joint effort to explore the production of the medical radioisotope lutetium-177 at Bruce Power's Candu reactors.

DOE funding for advanced nuclear technology R&D

Nuclear Policies

19 June 2018

The US Department of Energy's (DOE's) Office of Nuclear Energy has awarded nearly USD64 million to 89 projects for nuclear energy research, facility access and crosscutting technology and infrastructure development. The funds will be provided to DOE national laboratories, industry and 39 US universities in 29 states.

Petten reactor starts supplying Xenon-133

Regulation and Safety

15 May 2018

Xenon-133 - 48The High Flux Reactor at Petten in the Netherlands is now producing the medical radioisotope Xenon-133. The move follows the successful collaboration between nuclear medicine company Curium and the Nuclear Research and Consultancy Group to develop and install a production process for the isotope.

Halden Reactor to be decommissioned

Corporate

28 June 2018

Halden research reactor - 48The board of directors of Norway's Institute for Energy Technology has decided to close the Halden Reactor permanently and to start its decommissioning. The board will not apply to extend its operating licence, which expires in 2020, and the reactor, which is currently shut down due to a safety valve failure, will not be restarted.

DR Congo research reactor requires improvement, says IAEA

Regulation and Safety

17 May 2018

Organisational and technical measures are needed to improve the safety of the Democratic Republic of Congo's research reactor, an International Atomic Energy Agency team of experts has concluded. TRICO-II, at the Kinshasa Nuclear Research Centre (CREN-K), has not been in operation since 2003.

BWXT announces new Mo-99 technology

Regulation and Safety

08 May 2018

BWXT_Tc-99m_generator_(BWXT)-48 BWX Technologies Inc has developed an innovative process developed to manufacture molybdenum-99 which it says is a breakthrough for medical radioisotope manufacturing technology. The company plans to introduce the technology by the end of 2019, subject to regulatory approvals.